Inspire Medical Systems (NYSE: INSP) reported third-quarter revenue that missed the Wall Street analysts consensus. However, the Minneapolis-based implantable sleep therapy device company also upped its full-year guidance. Investors appeared to focus on the downside after Inspire’s Q3 earnings report yesterday evening. By midday trading today, INSP shares were down more than 16% to $134.90 […]
Neuromodulation/Neurostimulation
Onward spinal cord stimulation demonstrates improved mobility in study
Onward Medical announced a new publication demonstrating the impact of its ARC therapy to address gait challenges related to Parkinson’s disease. Eindhoven, the Netherlands-based Onward designed its ARC-IM stimulation system to deliver targeted, programmed therapy to the spinal cord. It aims to restore movement and other functions after spinal cord injury. The study, published in Nature […]
CVRx scores Medicare win on outpatient Barostim payments
CVRx (Nasdaq:CVRX) announced today that the Centers for Medicare and Medicaid Services (CMS) reassigned its Barostim implant procedure. The CMS change assigns the CVRx neuromodulation implant for procedures performed in the outpatient setting. It comes as part of the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule. Barostim’s reassignment brings it to New Technology […]
Neuromod tech developer Cognito Therapeutics has a new CCO
Cognito Therapeutics announced today that it named Christian Howell as its new chief commercial officer (CCO). Cambridge, Massachusetts–based Cognito Therapeutics develops a non-invasive neuromodulation device that delivers proprietary gamma frequency light and sound stimulation. The company’s investigational device is intended to treat Alzheimer’s disease. Howell joins the company with more than 20 years of medical […]
FDA clears non-invasive insomnia-treating device from Neurovalens
Neurovalens announced today that the FDA granted clearance to its Modius Sleep device for treating chronic insomnia. Belfast, Northern Ireland-based Neurovalens develops non-invasive neurotechnology. The company took part in the MedTech Innovator Accelerator program last year. Neurovalens designed Modius to deliver non-invasive electrical stimulation to key areas of the brain and nervous system. It eliminates […]
Butterfly Network is bringing its ultrasound tech to the BCI space
Butterfly Network (NYSE:BFLY) announced today that it entered into a five-year co-development deal with Forest Neurotech. The deal combines Butterfly Network’s portable ultrasound technology with Forest Neurotech’s minimally invasive brain device. Forest, a deep tech research company, develops a device for imaging and stimulating the brain with ultrasound. Forest Neurotech develops an ultrasound-based brain-computer interface […]
BrainsWay has positive data for its deep transcranial magnetic stimulation tech
BrainsWay (Nasdaq:BWAY) today announced new real-world, post-market data demonstrating the efficacy of its brain stimulation technology. The data supports the use of BrainsWay’s accelerated deep transcranial magnetic stimulation (Deep TMS) for treating major depressive disorder (MDD). Results were published in the peer-reviewed journal Psychiatry Research. Deep TMS uses specially designed H-coils to stimulate deep and broad cortical […]
Boston Scientific wins expanded indication for SCS system
The FDA has greenlit an expanded indication for the WaveWriter Alpha spinal cord stimulator systems from Boston Scientific . The approval now includes the treatment of painful diabetic peripheral neuropathy, a diabetes complication affecting the lower extremities. Diabetic neuropathy, a form of nerve damage often found in the legs and feet, is caused by prolonged […]
FDA approves next-gen intrathecal drug delivery system from Medtronic
Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity. The targeted drug delivery (TDD) system alleviates symptoms by delivering medication directly to the fluid surrounding the spinal cord. SynchroMed III builds upon […]
Biotronik has positive data for its spinal cord stimulation tech
Biotronik today announced positive results from a clinical trial for its Neuro Prospera spinal cord stimulation (SCS) system. The BENEFIT-02 trial evaluates the Resonance multiphase stimulating paradigm used in the Neuro Prospera system. It looked at the safety and effectiveness of the stimulator in treating patients with chronic pain. Contrary to other currently available SCS […]
How Onward uses spinal cord stimulation — and perhaps BCI — to restore movement
The brain-computer interface space has taken medtech by storm. This novel approach from Onward has the potential to bring it to another level. Several companies are developing brain-computer interfaces (BCIs), many of which offer people with paralysis a chance to control external devices with their mind. Onward, a Dutch medtech company, develops technology that could […]